Geode Capital Management’s EnteroMedics Inc. ETRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-26,825
| Closed | -$47K | – | 4139 |
|
|
2017
Q3 | $47K | Hold |
26,825
| – | – | ﹤0.01% | 3945 |
|
|
2017
Q2 | $134K | Sell |
26,825
-4,776
| -15% | -$23.8K | ﹤0.01% | 3781 |
|
|
2017
Q1 | $182K | Buy |
31,601
+18,168
| +135% | +$134K | ﹤0.01% | 3693 |
|
|
2016
Q4 | $26K | Buy |
13,433
+13,059
| +3,492% | +$68.5K | ﹤0.01% | 3982 |
|
|
2016
Q3 | $3K | Hold |
374
| – | – | ﹤0.01% | 4028 |
|
|
2016
Q2 | $7K | Hold |
374
| – | – | ﹤0.01% | 4057 |
|
|
2016
Q1 | $25 | Hold |
374
| – | – | ﹤0.01% | 4041 |
|
|
2015
Q4 | $51K | Hold |
374
| – | – | ﹤0.01% | 4004 |
|
|
2015
Q3 | $102K | Buy |
374
+125
| +50% | +$39.9K | ﹤0.01% | 3891 |
|
|
2015
Q2 | $161K | Buy |
249
+1
| +0.4% | +$1.15K | ﹤0.01% | 3650 |
|
|
2015
Q1 | $238K | Hold |
248
| – | – | ﹤0.01% | 3513 |
|
|
2014
Q4 | $369K | Hold |
248
| – | – | ﹤0.01% | 3325 |
|
|
2014
Q3 | $319K | Buy |
248
+38
| +18% | +$55.7K | ﹤0.01% | 3371 |
|
|
2014
Q2 | $343K | Hold |
210
| – | – | ﹤0.01% | 3329 |
|
|
2014
Q1 | $401K | Hold |
210
| – | – | ﹤0.01% | 3239 |
|
|
2013
Q4 | $449K | Buy |
210
+1
| +0.5% | +$1.61K | ﹤0.01% | 3133 |
|
|
2013
Q3 | $275K | Hold |
209
| – | – | ﹤0.01% | 3188 |
|
|
2013
Q2 | $250K | Buy |
+209
| New | +$221K | ﹤0.01% | 3163 |
|
Other funds holding ETRM
Geode Capital Management's ETRM Position: Q4 2017 in Review
Geode Capital Management sold out of EnteroMedics Inc. (ETRM) in Q4 2017, closing a stake of 26,825 shares — an estimated $47K sold.
Geode Capital Management first reported a position in ETRM in Q2 2013 and held it in 18 quarters. The position peaked at $449K in Q4 2013. 1 fund tracked by Wall St. Rank holds ETRM as of Q4 2017.
- Geode Capital Management reported no remaining EnteroMedics Inc. position as of Q4 2017 after selling out during the quarter.
- Geode Capital Management sold 26,825 EnteroMedics Inc. shares in Q4 2017, an estimated $47K.
- Geode Capital Management first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 18 quarters.
- Geode Capital Management's EnteroMedics Inc. position peaked at $449K in Q4 2013.
- 1 fund tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2017.
Based on Geode Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.